http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0995483-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9822bceff022feda91b10019125e70f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
filingDate 1996-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6100b17bd895360c566b1558b18d3c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94c4bdbf63898e4cec21ca862754e5e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f6c52dca89fa85cc121512e3eef4be3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffdaf3e1f4a5b3dcccfbc9f03ff1d1c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3407e5094881790e32b7c69042b7edcf
publicationDate 1997-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0995483-A
titleOfInvention (11E) -5-Amino-11-ethylidene-5,6,9,10-tetrahydro-7-methyl-5,9-methanocycloocta [b] pyridin-2 (1H) -one derivative and its production intermediate
abstract (57) Abstract: [PROBLEMS] To provide a novel compound which is expected to have an excellent pharmacokinetic effect as a therapeutic agent for Alzheimer's disease and an intermediate for producing the same. SOLUTION: (11E) represented by the following general formula [I] -5-amino-11-ethylidene-5,6,9,10- A compound represented by the following general formulas [II] to [IV], which is a tetrahydro-7-methyl-5,9-methanocycloocta [b] pyridin-2 (1H) -one derivative and a production intermediate thereof. Embedded image (In the formula, R and R ′ both represent a trifluoromethyl group, or one of them represents a trifluoromethyl group and the other represents a methyl group. R 1 represents an alkyl group or a silyl group, R 2 represents a hydrogen atom or a silyl group. X is a hydroxymethyl group; a formyl group; a carboxyl group; an amino group; It represents an alkyl, alkenyl or aralkyloxymethyl group; an alkyl, alkenyl or aralkyloxycarbonyl group; an alkyl, alkenyl or aralkyloxycarbonylamino group. )
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016185949-A
priorityDate 1995-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70079177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5912039
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9860965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234372198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226974040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233022251

Total number of triples: 25.